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(57) ABSTRACT 
Disclosed are apparatus and methods for depositing solvent-
free molecules on surfaces of samples, with particular appli-
cation to imaging mass spectrometry. A vacuum chamber is 
configured to have controllable matrix translation apparatus 
for controlling the position of one or more solvent-free matri-
ces within the chamber. Sublimation apparatus is used to 
sublimate molecules from the solid phase matrices. One or 
more samples are placed separately from the solvent-free 
matrices within the chamber. Condensation apparatus indi-
vidually cools the samples to deposit sublimated molecules 
on the samples. Controllable sample translation apparatus is 
used to control the position of the samples within the cham-
ber. Rotatable sample holding apparatus may be used to hold 
and move the samples to allow deposition of molecules on 
multiple samples at substantially the same time. Rotatable 
matrix holding apparatus may also be used to hold and move 
a plurality of matrices to create a homogenous mixture of 
molecules that are deposited onto one or more samples. As 
surface characterization system may be used to monitor depo-
sition of the molecules to determine their thickness and 
roughness. A computer may be configured to control the 
matrix translation apparatus, the sublimation apparatus, the 
condensation apparatus, and the sample translation apparatus 
to provide for automated deposition of solvent-free mol-
ecules on the samples. 
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DISPOSE ONE OR MORE SOLVENT-FREE 51 
MATRICES WITHIN A VACUUM CHAMBER 
• DISPOSE ONE OR MORE SAMPLES ARE WITHIN THE VACUUM CHAMBER 52 
DISTAL FROM THE ONE OR MORE SOLVENT-FREE MATRICES 
• EVACUATE THE VACUUM CHAMBER 53 
+ 
INDIVIDUALLY HEAT EACH SOLVENT-FREE MATRIX 1--- 54 
TO A DESIRED TEMPERATURE TO SUBLIMATE 
SOLVENT-FREE MOLECULES THEREFROM 
• INDIVIDUALLY COOL EACH SAMPLE TO A DEISRED i.-- 55 
TEMPERATURE TO DEPOSIT THE SUBLIMATED 
SOLVENT-FREE MOLECULES ON THE SAMPLES 
• ADJUST THE RELATIVE POSITIONS OF EACH SOLVENT-FREE i--- 56 
MATRIX AND EACH SAMPLE TO OPTIMIZE DEPOSITION OF THE 
SUBLIMATED SOLVENT-FREE MOLECULES ON THE SAMPLES 
+ 
OPTIONALLY GUIDE THE SUBLIMATED SOLVENT-FREE MOLECULES 
I---
TOWARD THE SAMPLES TO IMPROVE MOLECULAR COATING OF THE 
57 
SAMPLES, MINIMIZE MATRIX LOSS AND REDUCED CONTAMINATION 
OPTIONALLY INJECT ADDITIVES INTO THE 58 
CHAMBER TO ENHANCE DEPOSITION 
OPTIONALLY MONITOR AND CHARACTERIZE THE i..-- 59 
THICKNESS AND ROUGHNESS OF THE DEPOSITED 
SOLVENT-FREE MOLECULES TO OPTIMIZE DEPOSITION 
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METHOD AND APPARATUS OF UNIFORM 
GAS-PHASE MOLECULAR MATRIX 
DEPOSITION FOR IMAGING MASS 
SPECTROMETRY 
This application claims the benefit of U.S. Provisional 
Application No. 60/941,026, filed May 31, 2007. 
BACKGROUND 
2 
lyte crystals across the sample surface results." Thus, U.S. 
Pat. No. 5,643,800 discloses sublimation of a solvent that has 
been placed on a surface to create a crystalline surface on a 
sample. 
As evidenced by its abstract, U.S. Pat. No. 5,854,486 dis-
closes that a "thin uniform film of matrix material is deposited 
from the gas phase on to a substrate for use in Matrix Assisted 
Laser Desorption and Ionization (MALDI) spectroscopy. The 
thin uniform film of material may be overcoated with another 
The present invention relates generally to mass spectrom-
etry, and more particularly to solvent-free matrix deposition 
apparatus and methods using sublimation for imaging mass 
spectrometry. 
10 film of material which has a higher vapor pressure than the 
matrix material to prevent the matrix material from evaporat-
ing during storage and during substantial time in the vacuum 
environment of the mass spectrometer." The Summary of the 
Invention section of U.S. Pat. No. 5,854,486 states that "A 
Matrix-assisted laser desorption/ionization imaging mass 
spectrometry (MALDI-IMS) is a revolutionary and emerging 
technique for profiling and mapping biomolecules and study-
ing related biological processes directly from the samples. 
MALDI-IMS is discussed by M. Stoeckli, et al., in "Imaging 
mass spectrometry: A new technology for the analysis of 
protein expression in mammalian tissues", Nat Med, 7, 2001, 
493-496, for example. 
15 thin, uniform film of matrix material is deposited on a sub-
strate by sublimation of the solid matrix material or by other 
vapor deposition methods." U.S. Pat. No. 5,854,486 discloses 
a colunm 5, lines 20-25 that "The analyte material 50 may be 
deposited on the matrix material of layer 20 by a number of 
Based on its potential of simultaneously providing identi-
fication and spatial localization of most molecules of interest 
20 techniques. The easiest of such techniques is merely to drop a 
drop of solution containing the analyte material, a volatile 
solvent, and optionally matrix material on the surface of the 
layer 20 and to allow the volatile component of the solution to 
in complicated biological samples such as tissues and cells, 25 
imaging mass spectrometry has been recognized as a prom-
ising tool for numerous applications including peptide/pro-
tein, lipid, metabolite analysis, biomarker discovery, drug 
biodistribution monitoring, molecular mechanism investiga-
tion, etc. This is discussed by R. Lemair, et al., in "MALDI- 30 
MS Direct Tissue. Analysis of Proteins: Improving Signal 
Sensitivity Using Organic Treatments", Anal Chem, 78, 2006, 
7145-7153, for example. 
Uniformly coating the matrix onto sample surfaces is one 
of the most critical experimental factors in MALDI-IMS. The 35 
reproducibility and quality of MALDI imaging analyses are 
greatly affected by the size and homogeneity of the matrix 
cluster/crystal as well as the inevitable analyte spreading 
caused by solvents used for matrix deposition. 
Currently, there are two generally-used methods for matrix 40 
deposition: spraying and spotting. Both of them have a com-
mon problem of using solvents as media to transfer the matrix 
onto the sample surface. It is impossible to avoid lateral 
movement of the analytes with the existence of solvents, 
which reduces the signal intensity and resolution of molecu- 45 
lar imaging. In addition, spraying and spotting techniques 
have other limitations, such as high irreproducibility, poor 
control of matrix/analyte incorporation, slow coating pro-
cess, and alkali metal contamination (Nat or K). 
A number of U.S. patents have been issued relating to 50 
ionization mass spectrometry. U.S. Pat. No. 5,643,800 
entitled "Method of preparing a sample for analysis by laser 
desorption ionization mass spectrometry" issued Jul. 1, 1997, 
U.S. Pat. No. 5,854,486 entitled "Method and apparatus for 
MALDI mass spectrometry" issued Dec. 29, 1998, and U.S. 55 
Pat. No. 6,104,028 entitled "Volatile matrices for matrix-
assisted laser desorption/ionization mass spectrometry" 
issued Aug. 15, 2000. 
As evidenced by its abstract, U.S. Pat. No. 5,643,800 dis-
closes "a sample preparation system and method that can be 60 
used with all types of analyte materials, that produces homo-
geneously deposited crystals across a sample surface, and that 
lends itself to automation. In this system and method, analyte 
crystallization is caused by lyophilization. A homogeneous 
analyte/solvent mixture is placed on a sample surface. The 65 
mixture is frozen, then the solvent is sublimated through the 
application of a vacuum. A homogenous distribution of ana-
evaporate." 
The abstract of U.S. Pat. No. 6,104,028 states that a 
"sample preparation method is disclosed for volatilization 
and mass spectrometric analysis of nonvolatile high molecu-
lar weight molecules. Photoabsorbing molecules having sig-
nificant sublimation rates at room temperature under vacuum, 
and preferably containing hydroxy functionalities, are dis-
closed for use as matrices in matrix-assisted laser desorption/ 
ionization mass spectrometry. The samples are typically 
cooled in the mass spectrometer to temperatures significantly 
below room temperature." The Summary of the Invention 
section of U.S. Pat. No. 6,104,028 discloses "a method for 
determining the mass of a large organic molecule" and that 
the sample preparation method uses "liquids or low sublima-
tion temperature solids as matrices because such systems 
generally enable lower desorption/ionization temperatures." 
However, U.S. Pat. No. 6,104,028 discloses that "In creating 
the matrix:molecule mixture, for example, by dissolving the 
large organic molecule in a solution containing the matrix, 
one of skill in the art will understand that the solution con-
taining the matrix may generally contain one or more sol-
vents." 
However, none of the above-cited patents discloses or sug-
gests formation of a solvent-free matrix using sublimation 
techniques. In addition, there are no conventional molecular 
matrix deposition systems that have matrix (source) and 
sample (target) movement systems or stages for optimizing 
sublimation-condensation position and mixed matrix deposi-
tion. Furthermore, no conventional molecular matrix deposi-
tion system employs apparatus that permits substantially 
homogeneous deposition of molecules from multiple matri-
ces on one or multiple samples. Finally, no conventional 
molecular matrix deposition system employs apparatus that 
permits deposition of matrix molecules on multiple samples 
at substantially the same time. 
It would be desirable to overcome the limitations offered 
by conventional matrix deposition approaches. It would be 
desirable to have solvent-free matrix deposition apparatus 
and methods for use in imaging mass spectrometry and other 
surface coating processes. It would be desirable to have appa-
ratus and methods that provide uniform gas-phase molecular 
solvent-free matrix deposition for imaging mass spectrom-
etry and other surface coating processes. It would be desirable 
to have apparatus and methods that form a solvent-free matrix 
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3 
on a sample using sublimation techniques. It would be desir-
able to have apparatus and methods that advantageously 
employ uniform gas-phase molecular solvent-free matrix 
deposition to coat surfaces of materials. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The various features and advantages of the present inven-
tion may be more readily understood with reference to the 
following detailed description taken in conjunction with the 
accompanying drawings, wherein like reference numerals 
designate like structural elements, and in which: 
FIG. 1 illustrates exemplary solvent-free matrix vapor 
deposition apparatus; 
FIG. la illustrates exemplary rotatable matrix and sample 
holding apparatus that may be employed in the deposition 
apparatus shown in FIG. 1; 
FIGS. 2a-2d are mass spectrometry images of lipid mol-
ecules in different brain sections obtained using the reduced-
to-practice solvent-free matrix vapor deposition apparatus 
shown in FIG. 1; and 
FIG. 3 is a flow diagram that illustrates an exemplary 
solvent-free matrix deposition method. 
DETAILED DESCRIPTION 
Disclosed are universal solvent-free (i.e., powder) matrix 
deposition apparatus and methods for coating samples with 
molecules that are particularly useful in imaging mass spec-
trometry. The apparatus and methods may be used in numer-
ous applications including peptide/protein, lipid, metabolite 
analysis, biomarker discovery, drug biodistribution monitor-
ing, disease stage assessment, molecular mechanism investi-
gation, and the like. The apparatus and related methods 
advantageously employ uniform gas-phase molecular sol-
vent-free matrix deposition. 
Deposition of molecules from solvent-free matrices pro-
vided by the apparatus and methods greatly improves spatial 
resolution and detection sensitivity. The apparatus and meth-
ods automatically provide precise control of matrix deposi-
tion. The apparatus and methods provide uniform high-
throughput deposition of matrix mixtures onto samples. The 
apparatus and methods provide high-throughput matrix depo-
sition onto large samples or multiple samples at substantially 
the same time. 
4 
tion, control matrix/analyte mixing and optimize the signal 
intensity attainable by imaging mass spectrometers. 
The methods and apparatus embody the use of gas-phase 
molecular sublimation and condensation to apply a fine and 
even layer of molecules of a solvent-free matrix on sample 
surfaces. The methods and apparatus also control sample 
delivery, control matrix delivery through adjustments of 
quantity, sample position, film coating pattern, condensation 
condition, sublimation condition, vapor dosage, vacuum 
10 level, surface characterization and process automation. 
Using the apparatus and methods, the matrix molecules are 
evenly deposited on sample surfaces with optimized thick-
ness, while analyte diffusion and other effects caused by 
conventional solvent typically applied to the sample are 
15 eliminated. This approach may be used with essentially any 
solvent-free matrix, sample, and instrument. It overcomes the 
common problems of conventional matrix coating protocols 
and can be easily integrated into mass spectrometry technol-
ogy to provide sensitive, reproducible, fast, and direct profil-
20 ing and mapping of molecules in most biological systems 
with high spatial resolution. 
The present inventors have found that application of mol-
ecules from a solvent-free matrix to a sample using sublima-
tion-condensation overcome many of the shortcomings of 
25 conventional matrix deposition approaches. The disclosed 
methods and apparatus controls all variables for matrix depo-
sition onto samples as vapor without the use of solvents. The 
methods and apparatus utilize controls for vacuum, heat, 
condensation, sample positioning, and patterning of deposi-
30 tion as well as practical attachments for a variety of sample 
plates commonly used for MALDI applications. 
The use of matrix and sample position control systems 
optimizes sublimation-condensation position of the sample. 
The use of multiple matrix sources to create a homogenous 
35 mixture of multiple different molecules permits mixed matrix 
deposition onto samples. In particular, the use of the rotatable 
matrix holding apparatus permits substantially homogeneous 
deposition of molecules from multiple matrices onto one or 
multiple samples. The use of the rotatable sample holding 
40 apparatus permits deposition of matrix molecules onto mul-
tiple samples at substantially the same time. 
The disclosed methods and apparatus thus facilitates fast, 
simple, and reproducible molecular deposition of matrix mol-
ecules on biological surfaces using a simple operation to yield 
45 excellent images of the localization of biomolecules. The 
apparatus and methods disclosed herein may also be used in 
applications other than imaging mass spectrometry, such as 
film growth, surface modification, and molecular printing for 
The apparatus and methods embody matrix and sample 
position control systems or stages that optimize sublimation-
condensation position and mixed matrix deposition. The 
apparatus and methods may embody a rotatable matrix hold- 50 
ing apparatus that permits substantially homogeneous depo-
sition of molecules from multiple matrices onto one or mul-
tiple samples. This overcomes the shortcoming of using 
liquid (solvent) matrices which produce an uneven coating 
and introduce undesirable sodium (Na) and potassium (K) 
into the coating. The apparatus and methods may also employ 
optimized performances. 
Referring to the drawing figures, FIG. 1 illustrates exem-
plary solvent-free matrix vapor deposition apparatus 10. FIG. 
1 also illustrates an experimental protocol for uniform 
molecular deposition based on sublimation. However, it is to 
be understood that other configurations of components mak-
55 ing up the apparatus 10 shown in FIG. 1 may be employed to 
implement the principles disclosed herein. Therefore, it is to 
be understood that the embodiment shown in FIG. 1 should 
not limit the scope of the apparatus 10 and methods 50 (FIG. 
a rotatable sample holding apparatus that permits deposition 
of matrix molecules on multiple samples at substantially the 
same time. 3) disclosed herein. 
As is shown in FIG. 1, the exemplary solvent-free matrix 
vapor deposition apparatus 10 comprises a processing cham-
ber 11 or housing 11. AnXYZ translation stage 12 (position-
ing stage 12) may be disposed on a base or bottom plate of the 
processing chamber 11. The XYZ translation stage 12 is 
More particularly, disclosed herein are methods and appa- 60 
ratus for depositing uniform layers of matrix molecules on 
surfaces, such as biological and surfaces for analysis of cells 
and tissues using mass spectrometric imaging techniques. 
The improved quality of the deposited molecules greatly 
improves molecular imaging of samples using mass spec-
trometry. The apparatus and methods minimize analyte dif-
fusion, simplify sample preparation, increase spatial resolu-
65 coupled to an XYZ position controller 41. 
A thermal insulation layer 13 is disposed on the XYZ 
translation stage 12. A heating stage 14 is disposed on the 
US 7,880,139 B2 
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thermal insulation layer 13. The heating stage 14 is coupled 
by way of an electrical connector 31 that extends through the 
processing chamber 11 to a heating temperature controller 42. 
A sublimation system 15 is formed by the thermal insulation 
layer 13 and the heating stage 14. The sublimation system 15 
converts a powered, solvent-free, sample 20 directly into a 
gas without passing through an intermediate liquid phase. 
In one embodiment, a dock 16 or matrix holding apparatus 
16 comprising a temperature readout l6a is disposed above 
the heating stage 14. The temperature readoutl 6a coupled by 1 o 
way of the electrical connector 31 to provide a heating tem-
perature reading 43. A matrix container 17 is held by the dock 
6 
perature controller 42. Cooling lines 23a extend through the 
top plate of the processing chamber 11 through a cooling 
liquid feedthrough 37 that pass through a sample positioning 
system 36 or stage 36 that permits the flow of coolant to and 
from the cooling plate 23 or stage 23 to assist in dissipating 
heat from the cooling stage 23. It is to be understood that the 
sample positioning system 36 may be a rotational stage or a 
second XYZ translational stage that permits controlled move-
ment of the position of the sample 20 to assist in providing 
optimized deposition parameters. 
The first and second temperature readouts l6a, 22, are 
connected to a computer 40 to provide the first and second 
temperature readings 43 thereto. An output of the temperature 
controller 42 is connected to the computer 40. An output of 
16 or matrix holding apparatus 16 above the sublimation 
system 15. The matrix container 17 holds a sample of solvent-
free matrix material 17 a. 15 the XYZ position controller 41 is connected to the computer 
40. In another embodiment, and with reference to FIG. la, a 
rotatable matrix holding apparatus 16 may be used in place of 
the single dock 16 to hold and rotate a plurality of matrix 
containers 17 and plurality of solvent-free matrices 17 a above 
the sublimation system 15. A plurality of different heating 20 
plates 14 or stages 14 are respectively disposed beneath each 
container 17 held by the rotatable matrix holding apparatus 
16 so that individual sublimation temperatures can be accu-
rately controlled for each matrix. A motor (not shown) may be 
used to rotate the rotatable matrix holding apparatus 16 (indi- 25 
cated by the arrow to the right of the rotatable matrix holding 
apparatus 16). The use of multiple matrices 17a that are 
rotated within the chamber 11 by the rotatable matrix holding 
apparatus 16 create a homogenous mixture of different mol-
ecules substantially within the confines of the guiding system 30 
18 and permits mixed matrix deposition onto one or more 
samples 20. 
A molecule guiding system 18 is disposed above the matrix 
container 17. The molecule guiding system 18 provides for 
improved molecular coating, minimum matrix loss and 35 
reduced device contamination because it keeps the subli-
mated matrix molecules in a relatively confined space within 
the chamber 11 so that they more efficiently deposit on the 
sample 20. 
The processing chamber 11 has a dosing line/vacuum con-
trol pumping system 32, or dosing system 32, that is con-
nected to the computer 40. Typical vacuum pumps used to 
evacuate the vacuum chamber 11 normally cannot accurately 
control the vacuum within the chamber 11. The use of the 
dosing system 32 allows precise control of the pressure in the 
chamber 11 and permits addition of desired substances into 
the chamber 11 to enhance matrix deposition 
The processing chamber 11 has a surface characterization 
system 33 that may be used to monitor the thickness and 
roughness of the surface deposited on the sample 20. The 
surface characterization system 33 may be used to monitor 
and optimize deposition of matrix molecules on the sample 
20. 
The processing chamber 11 has a sample handling system 
34, or sample transfer system 34, that is connected to the 
computer 40 and which allows an operator to insert and 
remove samples from the sample chamber 19 under the con-
trol of the computer 40. 
A vacuum readout device 35 is provided on the processing 
chamber 11 which allows an operator to determine the 
amount of vacuum that exists within the processing chamber 
11. The sample positioning system 36 or rotation stage 36 is 
disposed adjacent the top of the processing chamber 11 and is 
coupled to a sample position controller 44. The sample posi-
tion controller 44 is connected to the computer 40 to allow 
control of the position of the cooling plate 23 or stage 23 and 
sample 20 to optimize deposition parameters. The surface of 
A masking system 21 is disposed between the molecule 40 
guiding system 18 and a sample adapter 19 containing a 
sample 20. The masking system 21 is used to pattern deposi-
tion of the solvent-free molecules on the sample 20 and pro-
vide for selected region deposition of the solvent-free mol-
ecules on the sample 20. 
In one embodiment, a sample holding apparatus 22 is dis-
posed above the sample adapter 19 and holds the sample 
adapter 19. The sample holding apparatus 22 comprises a 
cooling temperature readout 22 that is coupled by way of the 
electrical connector 31 to provide a cooling temperature read- 50 
ing 43. 
45 the sample 20 must be cooled in a controlled fashion in 
conjunction with the amount of heat provided by the subli-
mation system 15 in order to properly deposit the molecules 
on its surface. 
In another embodiment, and with reference to FIG. la, a 
rotatable sample holding apparatus 22 is used to hold multiple 
sample chambers 19, that permits deposition of matrix mol-
ecules on multiple samples 20 at substantially the same time. 55 
Multiple cooling plates 23 are respectively disposed adjacent 
to the multiple sample adapters 19 so that individual cooling 
temperatures can be accurately controlled for each sample 20. 
The rotatable sample holding apparatus 22 is rotated while 
the molecules are sublimated and deposited on each sample 60 
20 as it passes by the guiding system 18. A motor (not shown) 
may be used to rotate the rotatable sample holding apparatus 
22 (indicated by the arrow to the right of the rotatable sample 
holding apparatus 22 in FIG. la). 
A cooling plate 23 or stage 23 is disposed above the sample 65 
holding apparatus 22. The cooling plate 23 or stage 23 is 
connected by way of the electrical connector 31 to the tern-
A vacuum pumping system 38 with a cold trap is coupled 
to the processing chamber 11 to precisely control the pressure 
within the housing 11. It provides proper pressures for matrix 
deposition or fast surface cleaning, The processing chamber 
11 has a matrix handling system 39, or matrix transfer system 
39, that is connected to the computer 40 and which allows 
manipulate the solvent-free matrix under control of the com-
puter 40. 
Thus, the processing chamber 11 comprises a vacuum sys-
tem equipped with multiple manipulation systems 12, 36 (i.e., 
the XYZ translation stage 12 and the sample positioning 
system 36). The cooling stage 23 and heating stage 14 are 
built into the chamber 11 that control sublimation and con-
densation processes. The heating stage 14 includes the matrix 
holding apparatus 16 which holds matrix containers 17. Each 
matrix holding apparatus 16 sits on its own heating plate 14 or 
stage 14 which is coupled to a separate temperature controller 
42 (temperature control module 42) that precisely heats the 
matrix container 17 to a specified temperature in the range of 
US 7,880,139 B2 
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25 to 600° C. All heating components are placed on the XYZ 
translation stage 12 at the bottom of the chamber 11. The 
cooling stage 23 may have a single sample chamber 19 
coupled to it, or multiple sample adapters 19 or holders 19 
coupled to it to provide for simultaneous deposition of matrix 
molecules on multiple samples 20. The multiple sample hold-
ers 19 are respectively attached to multiple cooling plates 23 
8 
phosphocholine standard was significantly enhanced and 
even more enhanced in samples with a sublimated matrix 
relative to samples with ESI matrix deposition. The gas phase 
solvent-free matrix deposition yields a higher quality and 
more reliable representation of in-situ phospholipid molecu-
lar species of mouse brain tissue sections than deposition by 
techniques utilizing solutions of matrix that are subsequently 
evaporated to crystallize the matrix. to provide accurate cooling in the temperature range of - 70 to 
70° C. Each sample holder 19 is mounted to a cooling plate 23 
with good thermal conductivity. 
The masking system 21 can controllably place masks in 
front of the samples 20 for patterning of matrix deposition or 
spot-selecting deposition of molecules. All cooling compo-
nents are connected to the rotation stage 36 (sample position-
ing system 36) which has rotational (or XYZ) movement 
capability and the cooling liquid feedthrough 37 to provide 
for cooling liquid circulation through the cooling plate 23 or 
stage 23. 
For the purposes of completeness, FIG. 3 is a flow diagram 
10 that illustrates an exemplary solvent-free matrix deposition 
method 50. The exemplary solvent-free matrix deposition 
method 50 may be implemented as follows. 
One or more solvent-free matrices 17 are disposed 51 
within a vacuum chamber 11. One or more samples 20 are 
15 disposed 52 within the vacuum chamber 11 distal from the 
one or more solvent-free matrices 17. The vacuum chamber 
11 is evacuated 53. Each solvent-free matrix 17 is individu-
ally heated 54 to a desired temperature to sublimate solvent-
The samples 20 can be aligned to matrix containers 17 for 
high throughput deposition of different types of matrices on 20 
multiple samples 20. The XYZ position controller 41 for the 
XYZ translation stage 12 is able to move the matrices 17 a up 
or down to reach the best position of matrix sublimation. The 
samples 20 can also be rotated (or translated) using the 
sample positioning system 36 multiple matrices in different 25 
matrix containers 17 may be heated to desired temperatures to 
obtain uniform coating of molecules from the solvent-free 
matrix mixtures. 
free molecules therefrom. Each sample 20 is individually 
cooled 55 to a desired temperature to deposit the sublimated 
solvent-free molecules on the samples 20. The relative posi-
tions of each solvent-free matrix 17 and each sample 20 is 
adjusted 56 to optimize deposition of the sublimated solvent-
free molecules on the samples 20. 
Optionally, the sublimated solvent-free molecules may be 
guided 57 toward the samples 20 to improve molecular coat-
ing of the samples 20, minimize matrix loss and reduced 
contamination. Optionally, additives are injected 58 into the 
chamber 11 to enhance matrix deposition. Optionally, the The molecule guiding system 18 may be configured to have 
a single channel or multiple channels to provide for improved 
molecular coating, minimized matrix loss, and reduced con-
tamination. The sample handling system 34 may be used to 
automatically or controllable move samples 20 onto the 
sample holders 19, while the matrix handling system 39 may 
30 thickness and roughness of the deposited solvent-free mol-
ecules are monitored and characterized 59 to optimize depo-
be used to add certain amounts of matrices into the matrix 35 
containers 17. 
sition. 
Thus, solvent-free matrix deposition apparatus and meth-
ods for use in imaging mass spectrometry have been dis-
closed. It is to be understood that the above-described 
embodiments are merely illustrative of some of the many 
specific embodiments that represent applications of the prin-
ciples discussed above. Clearly, numerous and other arrange-
ments can be readily devised by those skilled in the art with-
The automatic dosing-pumping system 32 may be used to 
control the vacuum level and vapor components during the 
sublimation-condensation process for optimized deposition 
performance. A turbo pump may be employed in the pumping 
system 38 to generate ultra-high vacuum conditions (as low 
as 10-10 Torr) to control surface cleaning and repeated depo-
sition. 
40 out departing from the scope of the invention. 
The surface characterization system comprises a deposi-
tion monitoring system 33 and software running on the com- 45 
puter 40 that may be used to monitor the thickness and rough-
ness of the deposited molecule layer and optimize deposition 
conditions. All sublimation-condensation and sample trans-
fer processes may be automatically controlled by the com-
puter 40 so that no user intervention is needed. 50 
What is claimed is: 
1. Molecule deposition apparatus comprising: 
a vacuum chamber; 
controllable matrix translation apparatus for controlling 
the position of solvent-free matrix material within the 
chamber whose molecules are to be deposited; 
sublimation apparatus for sublimating the molecules from 
the solvent-free matrix material; 
one or more solvent-free matrices whose position is con-
trollable by the controllable translation apparatus; 
one or more samples that are separated from the one or 
more solvent-free matrices; 
condensation apparatus for individually cooling the 
samples to deposit the sublimated molecules on the 
samples; and 
controllable sample translation apparatus for controlling 
the position of the samples within the chamber. 
A useful example of the benefits provided by the solvent-
free matrix vapor deposition apparatus 10 described above is 
the creation of excellent ion images of phospholipids likely 
derived from 16:0a/16:0-glycerophosphocholine (m/z 
734.6), 16:0a/18:1-glycerophosphocholine (m/z 760.6), 55 
18:0a/22:6-glycerophosphocholine (m/z 834.6), and a lipid 
fragment ion at m/z 577. Representative images showing 
mass spectrometry images of lipid molecules in different 
brain sections are illustrated in FIGS. 2a-2d. In particular, 
FIG. 2a shows m/z 734, FIG. 2b shows m/z 834, FIG. 2c 
shows m/z 577, and FIG. 2d shows m/z 761. 
2. The apparatus recited in claim 1 further comprising a 
60 masking system for patterning deposition of the solvent-free 
molecules on the sample. 
There are differences in definition and texture when com-
paring images of robotically spotted standards with different 
methods of matrix application that imply the occurrence of 
subtle spreading of lipids with ESI matrix deposition, and 
none using the gas phase matrix deposition as described 
herein. Signal intensity for a [M+Ht ion from a glycerol-
3. The apparatus recited in claim 1 further comprising 
molecule guiding apparatus for confining the sublimated 
molecules within the chamber so that they more efficiently 
65 deposit on the one or more samples. 
4. The apparatus recited in claim 1 further comprising 
rotatable sample holding apparatus for holding and moving 
US 7,880,139 B2 
9 
the one or more samples to allow deposition of molecules on 
multiple samples at substantially the same time. 
5. The apparatus recited in claim 1 further comprising 
rotatable matrix holding apparatus for holding and moving a 
plurality of solvent-free matrices to create a homogenous 
mixture of molecules that are deposited onto the one or more 
samples. 
6. The apparatus recited in claim 1 further comprising a 
dosing-pumping system that controls pressure in the chamber 
and permits addition of desired substances into the chamber. 10 
7. The apparatus recited in claim 1 further comprising a 
computer coupled to the controllable matrix translation appa-
ratus, the sublimation apparatus, the condensation apparatus, 
and the controllable sample translation apparatus, and a soft-
ware program that runs on the computer, for providing auto- 15 
mated deposition of solvent-free molecules on the samples. 
8. The apparatus recited in claim 1 further comprising a 
surface characterization system for monitoring deposition of 
the solvent-free molecules on the one or more samples to 
determine the thickness an roughness of the deposited mo!- 20 
ecules. 
9. Molecule deposition apparatus comprising: 
a vacuum chamber; 
controllable matrix translation apparatus for controlling 
the position of solvent-free matrix material within the 25 
chamber whose molecules are to be deposited; 
sublimation apparatus for sublimating the molecules from 
the solvent-free matrix material; 
a plurality of solvent-free matrices whose positions are 
controllable by the controllable translation apparatus; 30 
one or more samples that are separated from the one or 
more solvent-free matrices; 
rotatable sample holding apparatus for holding and moving 
the one or more samples to allow deposition of mol-
ecules on multiple samples at substantially the same 35 
time; 
10 
rotatable matrix holding apparatus for holding and moving 
the plurality of solvent-free matrices to create a homog-
enous mixture of molecules for deposition onto samples; 
one or more samples that are separated from the one or 
more solvent-free matrices; 
condensation apparatus for individually cooling the one or 
more samples to deposit the sublimated molecules on 
the samples; and 
controllable sample translation apparatus for controlling 
the position of the samples within the chamber. 
11. The apparatus recited in claim 10 further comprising 
rotatable matrix holding apparatus for holding and moving 
the plurality of solvent-free matrices to create a homogenous 
mixture of molecules for deposition onto samples. 
12. A molecule deposition method comprising: 
disposing one or more solvent-free matrices within a 
vacuum chamber; 
disposing one or more samples within the vacuum chamber 
distal from the one or more solvent-free matrices; 
evacuating the vacuum chamber; 
individually heating each solvent-free matrix to a desired 
temperature to sublimate solvent-free molecules there-
from; 
individually cooling each sample to a desired temperature 
to deposit the sublimated solvent-free molecules on each 
sample; 
adjusting the relative positions of each solvent-free matrix 
and each sample to optimize deposition of the subli-
mated solvent-free molecules on the samples. 
13. The method recited in claim 12 further comprising 
substantially simultaneously depositing molecules from the 
same solvent-free matrix onto multiple samples. 
14. The method recited in claim 12 further comprising 
substantially simultaneously depositing a homogeneous mix-
ture of molecules derived from different solvent-free matrices 
onto one or more samples. 
condensation apparatus for individually cooling the one or 
more samples to deposit the sublimated molecules on 
the samples; and 
controllable sample translation apparatus for controlling 
15. The method recited in claim 12 further comprising 
guiding the sublimated solvent-free molecules toward the 
samples to improve molecular coating of the sample, mini-
40 mize matrix loss and reduced contamination. 
the position of the samples within the chamber. 
10. Molecule deposition apparatus comprising: 
a vacuum chamber; 
controllable matrix translation apparatus for controlling 
the position of solvent-free matrix material within the 
chamber whose molecules are to be deposited; 
sublimation apparatus for sublimating the molecules from 
the solvent-free matrix material; 
a plurality of solvent-free matrices whose positions are 
controllable by the controllable translation apparatus; 
16. The method recited in claim 12 further comprising 
injecting additives into the chamber to enhance deposition 
and promote surface cleaning. 
17. The method recited in claim 12 further comprising 
45 monitoring and characterizing the thickness and roughness of 
the deposited solvent-free molecules to optimize deposition. 
18. The method recited in claim 12 further comprising 
masking the one or more samples to deposit patterns of free 
molecules on the one or more samples. 
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